Literature DB >> 14506712

Origins and early descriptions of "Duchenne muscular dystrophy".

Kenneth L Tyler1.   

Abstract

One of the seminal events in the history of neurology was the identification of primary diseases of muscle and their separation from diseases in which muscle weakness was secondary to injury involving the anterior horns of the spinal cord ("progressive muscular atrophy"). Not surprisingly, one of the first groups of primary muscle diseases to be satisfactorily characterized belonged to what would today be classified as muscular dystrophies. Pride of place in this group belongs to Duchenne muscular dystrophy (DMD). DMD's primacy as the first well-characterized muscular dystrophy was due both to the fact that it is relatively common, as well as to the clinically striking feature, apparent in many cases, of apparent paradoxical enlargement of severely weakened muscles ("pseudo-hypertrophy"). This review traces the historical roots of DMD in the 19th century, from the early papers by Conte, Bell, Partridge, and Meryon through the classic monographs by Duchenne and Gowers. In addition, the first American contributions to DMD are reviewed, including those by Pepper, Hammond, and S. Weir Mitchell. Many of the original papers describing this disease are now unavailable outside of major medical libraries, and several important contributions, excepting those of Duchenne, which are recognized eponymously, are now virtually forgotten.

Entities:  

Mesh:

Year:  2003        PMID: 14506712     DOI: 10.1002/mus.10435

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  20 in total

1.  High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia.

Authors:  Zoe White; Chady H Hakim; Marine Theret; N Nora Yang; Fabio Rossi; Dan Cox; Gordon A Francis; Volker Straub; Kathryn Selby; Constadina Panagiotopoulos; Dongsheng Duan; Pascal Bernatchez
Journal:  J Clin Lipidol       Date:  2020-05-29       Impact factor: 4.766

2.  Pathomechanics of Gowers' sign: a video analysis of a spectrum of Gowers' maneuvers.

Authors:  Richard F Chang; Scott J Mubarak
Journal:  Clin Orthop Relat Res       Date:  2011-12-28       Impact factor: 4.176

3.  'Double trouble': diagnostic challenges in Duchenne muscular dystrophy in patients with an additional hereditary skeletal dysplasia.

Authors:  Sandra Donkervoort; Alice Schindler; Carolina Tesi-Rocha; Allison Schreiber; Meganne E Leach; Jahannaz Dastgir; Ying Hu; Ami Mankodi; Kathryn R Wagner; Neil R Friedman; Carsten G Bönnemann
Journal:  Neuromuscul Disord       Date:  2013-08-11       Impact factor: 4.296

Review 4.  The paradox of muscle hypertrophy in muscular dystrophy.

Authors:  Joe N Kornegay; Martin K Childers; Daniel J Bogan; Janet R Bogan; Peter Nghiem; Jiahui Wang; Zheng Fan; James F Howard; Scott J Schatzberg; Jennifer L Dow; Robert W Grange; Martin A Styner; Eric P Hoffman; Kathryn R Wagner
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-02       Impact factor: 1.784

Review 5.  Gene therapy in large animal models of muscular dystrophy.

Authors:  Zejing Wang; Jeffrey S Chamberlain; Stephen J Tapscott; Rainer Storb
Journal:  ILAR J       Date:  2009

6.  Mapping contrast agent uptake and retention in MRI studies of myocardial perfusion: case control study of dogs with Duchenne muscular dystrophy.

Authors:  William S Kerwin; Anna Naumova; Rainer Storb; Stephen J Tapscott; Zejing Wang
Journal:  Int J Cardiovasc Imaging       Date:  2012-10-17       Impact factor: 2.357

Review 7.  Mechanical signals protect stem cell lineage selection, preserving the bone and muscle phenotypes in obesity.

Authors:  Danielle M Frechette; Divya Krishnamoorthy; Tee Pamon; M Ete Chan; Vihitaben Patel; Clinton T Rubin
Journal:  Ann N Y Acad Sci       Date:  2017-09-11       Impact factor: 5.691

8.  DMD carrier model with mosaic dystrophin expression in the heart reveals complex vulnerability to myocardial injury.

Authors:  Tatyana A Meyers; Jackie A Heitzman; DeWayne Townsend
Journal:  Hum Mol Genet       Date:  2020-04-15       Impact factor: 6.150

Review 9.  Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.

Authors:  Kristin Wilson; Crystal Faelan; Janet C Patterson-Kane; Daniel G Rudmann; Steven A Moore; Diane Frank; Jay Charleston; Jon Tinsley; G David Young; Anthony J Milici
Journal:  Toxicol Pathol       Date:  2017-10-03       Impact factor: 1.902

10.  Sarcoglycan complex: implications for metabolic defects in muscular dystrophies.

Authors:  Séverine Groh; Haihong Zong; Matthew M Goddeeris; Connie S Lebakken; David Venzke; Jeffrey E Pessin; Kevin P Campbell
Journal:  J Biol Chem       Date:  2009-06-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.